3BBLACKBIOBSE3B BLACKBIO DX LTD.MinimalNeutral
Announced Fri, 9 Oct, 2026 · 17:39 IST

RTA submits quarterly demat certificate under SEBI Regulation 74(5)

3BBLACKBIO · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
+0.4%Reaction day
₹1596.00
prior close
₹1586.40
announcement price
After-mkt
timing
Nifty Microcap 250market · in no size index; the smallest one is used+0.8%-0.5% vs market
Healthcare Service Provider peers, median of 27sector+0.5%-0.1% vs sector

On the reaction day the stock moved 0.5 pts less than Nifty Microcap 250 and 0.1 pts less than its Healthcare Service Provider peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
+0.2
10m
-0.2
15m
+0.2
30m
+1.2
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
+0.4+0.8-0.5+0.5-0.1
Next day
-4.9+1.0-5.9-0.1-4.8
2d
-9.0+1.7-10.7+0.5-9.4
3d
-8.7+0.1-8.7-0.6-8.1
4d
-9.1+0.8-9.9-1.0-8.1
5d
-16.9-0.9-16.0-1.1-15.7
1w
-13.9-4.5-9.4-2.6-11.3
15d
—————
1m
—————
2m
—————
3m
—————
UpDownMarket · Nifty Microcap 250Sector · Healthcare Service Provider peers, median of 27Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

3B BlackBio Dx Limited has filed a certificate under Regulation 74(5) of SEBI Depositories Regulations, 2018, for the quarter ended 30 September 2026. The certificate was submitted by Adroit Corporate Services Pvt. Ltd., the company's Registrar and Share Transfer Agent. It confirms that securities received from depository participants for dematerialisation were duly confirmed to the depositories, certificates were mutilated and cancelled, and the depository name was substituted as registered owner within 15 days.

Likely market impact

Routine regulatory compliance filing with no material impact on shareholders or the stock price.